Assessing AnaptysBio (ANAB) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
AnaptysBio, Inc. (ANAB)
Last anaptysbio, inc. earnings: 3/2 08:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anaptysbio.com/investor-relations
Company Research
Source: Yahoo! Finance
See our latest analysis for AnaptysBio. Beyond the recent moves, AnaptysBio's 3 month share price return of 42.4% and 1 year total shareholder return of 214.36% point to strong momentum, even though the year to date share price return is slightly negative. If AnaptysBio's recent surge has your attention, it could be a good moment to see how other biotech names stack up using our healthcare stocks With AnaptysBio trading at US$44.67, at a discount to both analyst targets and one estimate of intrinsic value, it is worth asking: is this a genuine opportunity, or is the market already factoring in future growth? AnaptysBio trades on a P/S of 7.3x, and at a last close of US$44.67 that multiple sits above its peer average but below the broader US biotech group. P/S compares the company's market value to its revenue, which is often used for biotech names that are still loss making but generating sales. For AnaptysBio, the 7.3x P/S is higher than the 5.1x peer average, which sugg
Show less
Read more
Impact Snapshot
Event Time:
ANAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANAB alerts
High impacting AnaptysBio, Inc. news events
Weekly update
A roundup of the hottest topics
ANAB
News
- What Investors Should Know About a $163K AnaptysBio Insider Sale [Yahoo! Finance]Yahoo! Finance
- What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally [Yahoo! Finance]Yahoo! Finance
- AnaptysBio (NASDAQ:ANAB) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.MarketBeat
- AnaptysBio Moves to Dismiss GSK's Tesaro Lawsuit Over Jemperli Royalty Dispute [Yahoo! Finance]Yahoo! Finance
- AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty [Yahoo! Finance]Yahoo! Finance
ANAB
Earnings
- 11/4/25 - Beat
ANAB
Sec Filings
- 1/9/26 - Form 4
- 1/9/26 - Form 144
- 1/9/26 - Form 4
- ANAB's page on the SEC website